Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials

AIDS. 2003 Jan 24;17(2):147-56. doi: 10.1097/01.aids.0000050786.28043.62.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • AIDS Vaccines*
  • Clinical Trials, Phase III as Topic
  • Government
  • HIV Infections / prevention & control*
  • Humans
  • Patient Selection
  • Research Design

Substances

  • AIDS Vaccines
  • AIDSVAX